PLSE Pulse Biosciences Inc



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

____________________

3957 Point Eden Way

Hayward, California 94545

(Address of principal executive offices, including zip code)

Brian B. Dow

Senior Vice President and Chief Financial Officer

(510) 906-4600

(Name and telephone number, including area code, of the person to contact in connection with this report)



____________________

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:







Section 1.      Conflict minerals disclsosure  



Item 1.01   Conflict Minerals Disclosure and Report  

A copy of Pulse Biosciences, Inc.’s (the “Company’s”) Conflict Minerals Report for the reporting period January 1, 2018 to December 31, 2018 is provided as Exhibit 1.01 hereto and is publicly available at www.pulsebiosciences.com. The Company’s determination and related disclosures relating to materials that may come from the Democratic Republic of Congo, the Republic of Congo, the Central African Republic, South Sudan, Uganda, Rwanda, Burundi, Tanzania, Zambia or Angola or from recycled and scrap sources that are included in the Company’s Conflict Minerals Report and incorporated by reference herein.



Item 1.02   Exhibit  

In accordance with Rule 13p-1, and this Form SD, the Company is hereby filing its Conflict Minerals Report for the calendar year ended December 31, 2018 as Exhibit 1.01 to this report.



Section 2.      Exhibits  

The following exhibits are filed as part of this report:



Item 2.01   Exhibits  

Exhibit 1.01 — 201 8 Conflict Minerals Report of Pulse Biosciences , Inc. as required by Items 1.01 and 1.02 of this Form SD.











SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





Date: May 24 , 201 9